Adma Biologics | ADMA - Market Capitalization

Stock Price
11.26
Daily Change
0.18 1.62%
Monthly
16.93%
Yearly
-48.49%
Q2 Forecast
11.02

Adma Biologics reported $2.62B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Adma Biologics USD 4.34B 845M Dec/2025
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
Novavax USD 1.09B 316M Dec/2025
Takeda JPY 7.64T 774.9B Dec/2025